| Filed On | Filing |
|---|---|
| 12 Nov 2026 |
Form 4: Konowiecki Joseph S, Director
Sold 4,930 shares ($35.5K) |
| 10 Nov 2026 | SCHEDULE 13G/A |
| 09 Nov 2026 | 144 |
| 05 Nov 2026 | SCHEDULE 13G/A |
| 29 Oct 2026 | 10-Q |
| 29 Oct 2026 |
8-K: Results of Operations and Financial Condition
ORANGE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its third quarter ended Sept. 30, 2026. |
| 08 Oct 2026 |
8-K: Regulation FD Disclosure
On October 8, 2026, the Centers for Medicare & Medicaid Services (“CMS”) released its 2027 Star Ratings for Medicare Advantage (“Medicare Part C”) and Medicare Part D prescription drug plans. Based on the newly released Star Ratings, Ali... |
| 07 Oct 2026 |
Form 4: Kim Hyong, Chief Medical Officer
Sold 32,479 shares ($270K) |
| 05 Oct 2026 | 144 |
| 05 Oct 2026 | SCHEDULE 13G/A |
| 18 Sep 2026 |
Form 4: Konowiecki Joseph S, Director
Sold 23,511 shares ($202K) |
| 16 Sep 2026 |
Form 4: Kao John E, Director
Sold 27,400 shares ($356K) |
| 16 Sep 2026 | 144 |
| 11 Sep 2026 |
Form 4: Maroney Dawn Christine, President
Sold 122,707 shares ($1.56M) |
| 11 Sep 2026 |
Form 4: Kao John E, Director
Sold 172,600 shares ($2.24M) · Sold 385,270 shares ($4.89M) |
| 10 Sep 2026 | 144 |
| 09 Sep 2026 | 144 |
| 09 Sep 2026 | 144 |
| 18 Aug 2026 |
Form 4: Maroney Dawn Christine, President
Sold 5,000 shares ($70K) |
| 14 Aug 2026 | 144 |
Loading...